+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macrolide Antibiotic"

DIFICID Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

DIFICID Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
From
From
Antibiotics Companies in China - Product Thumbnail Image

Antibiotics Companies in China

  • Report
  • December 2024
  • 123 Pages
  • China
From
Antibiotics Markets in China - Product Thumbnail Image

Antibiotics Markets in China

  • Report
  • December 2024
  • 267 Pages
  • China
From
Antibiotics Industry Forecasts - China Focus - Product Thumbnail Image

Antibiotics Industry Forecasts - China Focus

  • Report
  • December 2024
  • 94 Pages
  • China
From
Anti-Infectious Disease Drugs Markets in China - Product Thumbnail Image

Anti-Infectious Disease Drugs Markets in China

  • Report
  • August 2024
  • 229 Pages
  • China
From
Pregnancy and Anti-Infective Agents - Product Thumbnail Image

Pregnancy and Anti-Infective Agents

  • Book
  • November 2020
From
From
From
Loading Indicator

The Macrolide Antibiotic market is a segment of the Infectious Diseases Drugs market. Macrolides are a class of antibiotics used to treat a wide range of bacterial infections, including respiratory tract infections, skin infections, and sexually transmitted diseases. Macrolides are generally well-tolerated and have fewer side effects than other antibiotics. They are also effective against drug-resistant bacteria, making them an important tool in the fight against antibiotic resistance. Macrolides are available in both oral and intravenous formulations, and are often used in combination with other antibiotics. The Macrolide Antibiotic market is highly competitive, with a number of large pharmaceutical companies offering products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Show Less Read more